GPCR peptide

Galen's GPCR peptide campaign — 2 candidate(s) with published structures. The campaign reveals Galen's scientific process: families generated, structures folded, and portfolio decisions.

Structure metrics are computational priors, not biological proof. Predicted folds (ESMFold) and deterministic sequence-only proxies prioritize candidates for review; they do not establish biological activity, binding, stability, efficacy, safety, patentability, or clinical readiness. Wet-lab validation and human review are the downstream reality check.